PARIS & BOULDER, Colo.–(BUSINESS WIRE)–Regulatory Information:
SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an progressive firm that deploys its DSG® (Dynamic Surgical Steering) sensing know-how to safe and streamline the position of bone implants, experiences on its Annual Shareholders’ Assembly held on June 30, 2021, on its second name through a closed digital session and dwell webcast.
The Shareholders accredited by a big majority all of the bizarre resolutions supported by the Board of Administrators. Because the statutory quorum of 25% was not met to carry the Extraordinary Shareholder’ Assembly, the extraordinary resolutions weren’t resolved.
The Board of Administrators will set the modalities for convening a brand new Extraordinary Common Assembly at a later date.
The replay of the Shareholder’s Assembly and the votes of the resolutions can be found on the corporate’s web site, www.spineguard.com, underneath the part “Buyers/Documentation/Shareholders Assembly”. You can find the company presentation on advances and outlook underneath the part “Buyers/Documentation/Investor Sources”.
About SpineGuard®
Based in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an progressive firm deploying its proprietary radiation-free actual time sensing know-how DSG® (Dynamic Surgical Steering) to safe and streamline the position of implants within the skeleton. SpineGuard designs, develops and markets medical units which have been utilized in over 80,000 surgical procedures worldwide. Seventeen research revealed in peer-reviewed scientific journals have demonstrated the a number of advantages DSG® affords to sufferers, surgeons, surgical workers and hospitals. Constructing on these stable fundamentals and a number of other strategic partnerships, SpineGuard has expanded its know-how platform in a disruptive innovation: the « good » pedicle screw launched late 2017 and is broadening the scope of functions in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer.
For additional data, go to www.spineguard.com
Disclaimer
The SpineGuard securities will not be supplied or offered in the US as they haven’t been and won’t be registered underneath the Securities Act or any United States state securities legal guidelines, and SpineGuard doesn’t intend to make a public supply of its securities in the US. That is an announcement and never a prospectus, and the knowledge contained herein does and shall not represent a suggestion to promote or the solicitation of a suggestion to purchase, nor shall there be any sale of the securities referred to herein in the US by which such supply, solicitation or sale can be illegal previous to registration or exemption from registration.
